AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Jdsupra

Published October 31, 2026

Investing in Ketamine Clinics? Key Legal and Practical Considerations for Investors

Read the full story at Jdsupra

Interest in psychedelic-assisted psychotherapy, including treatments involving ketamine, psilocybin, and 3,4-Methylenedioxymethamphetamine ( MDMA ),.

Post on X

Share this story

Surfaced by 2 Google Alerts

MDMA
Ketamine